SÍLICA DE BASE BIOLÓGICA E SEUS USOS
Bamboo-derived mesoporous silica enhances the bioavailability of therapeutic and nutraceutical agents, addressing toxicity and cost concerns of chemical synthesis by providing a simpler, effective, and eco-friendly alternative.
Patent Information
- Application Number
- BR112025024583
- Authority / Receiving Office
- BR · BR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-05-12
- Filing Date
- 2024-05-13
- Publication Date
- 2026-11-10
AI Technical Summary
Chemically synthesized mesoporous silica poses toxicity risks and requires complex, expensive synthesis processes, limiting the bioavailability of therapeutic and nutraceutical agents.
A method using bamboo-derived mesoporous silica extract, formulated with biologically active compounds, enhances bioavailability through a simpler and more environmentally friendly process.
The bamboo silica extract achieves comparable bioavailability to synthetic mesoporous silica, improving the effectiveness of biologically active compounds without the toxicity and cost issues of chemical synthesis.
Abstract
Description
1 / 49 “BIOLOGICALLY BASED SILICA AND ITS USES” FIELD OF INVENTION
[0001] The present invention relates to an oral pharmaceutical composition and dosage form comprising mesoporous silica derived from a biological source, more particularly bamboo. In another aspect, the present invention also relates to a method for preparing said oral pharmaceutical composition and dosage form. BACKGROUND
[0002] Bioavailability is a critical factor in determining the efficacy of many therapeutic and nutraceutical agents. Low bioavailability can limit the therapeutic or other effects of these compounds and often requires high doses or frequent administration, which can lead to undesirable side effects.
[0003] Mesoporous silica is a widely used material to improve the bioavailability of active ingredients due to its high surface area and pore volume. However, the use of chemically synthesized mesoporous silica presents some disadvantages, such as the potential for toxicity and the need for expensive and complex synthesis procedures. There is a need for a simpler and more environmentally friendly process for the production of mesoporous silica.
[0004] Bamboo is a versatile plant with a long history of use in traditional medicine. Several studies have shown that bamboo is a rich source of silica.
[0005] The present invention provides a method for increasing the effectiveness of a wide range of biologically active ingredients by formulating them with a bamboo silica extract. The extract is obtained by a simple and economical process that preserves the bioactivity of the silica and other components. By incorporating the bamboo silica extract into formulations containing biologically active ingredients, the present invention provides a simple and effective way to improve the bioavailability of these compounds, avoiding potential Petition 870260002279, dated 09 / 01 / 2026, page 9 / 67 2 / 49 disadvantages associated with chemically synthesized mesoporous silica. SUMMARY OF THE INVENTION
[0006] The present invention and its embodiments serve to provide a solution to one or more of the disadvantages mentioned above. To this end, the present invention relates to a composition according to the first aspect. In a second aspect, the present invention relates to an oral pharmaceutical form comprising a composition according to the first and / or sixth aspect. In a third aspect, the invention relates to a composition according to the first and / or sixth aspect, for use as a medicament, more particularly for use in the treatment and / or prevention of cancer, inflammatory diseases, neurological disorders, neurodegenerative diseases, cardiovascular diseases, metabolic disorders, obesity or skin diseases.
[0007] In a fourth aspect, the invention relates to the use of any of the compositions provided herein to increase the bioavailability of a compound. In the first aspect, it is detailed how this can be achieved for a wide range of compounds. In the sixth aspect, it is detailed how this can be achieved for silicon itself. It is evident that these teachings can be easily combined to achieve high levels of silicon and solubility of other target compounds.
[0008] In a fifth aspect, the invention relates to a method of producing the compositions according to the invention.
[0009] In a sixth aspect, the invention relates to a composition comprising soluble silicon according to claim 1. In particular, said composition comprises bio-based silicon, preferably derived from bamboo, wherein the composition has been modified to improve the solubility and bioavailability of the silicon contained therein. In a seventh aspect, the invention relates to methods for producing compositions according to the sixth aspect, in accordance with claims 8 and 15. BRIEF DESCRIPTION OF THE FIGURES
[0010] Figure 1 shows the physisorption curves of the extract. Petition 870260002279, dated 09 / 01 / 2026, p. 10 / 67 3 / 49 of bamboo silica at liquid nitrogen temperature. The black curve corresponds to the gas adsorption phase on the solid surface, while the gray curve corresponds to the desorption phase. The hysteresis observed between the two curves is generally attributed to adsorption in mesoporous materials with capillary condensation.
[0011] Figure 2 illustrates the pore size distribution of bamboo silica extract.
[0012] Figure 3 shows the volumetric particle size distribution of bamboo silica extract, as determined by the Beckman Coulter method in water at room temperature.
[0013] Figure 4 shows the X-ray reflections of phloretin extracted from the dried root bark of Malus pumila.
[0014] Figure 5 shows a comparison of the X-ray reflections of solid dispersion phloretin 303DS02 (gray) and the physical mixture between pure crystalline phloretin material and bamboo silica extract (black).
[0015] Figure 6 illustrates the comparison of the release kinetics of phloretin from the solid dispersion 303DS02 (dark gray) and from the pure crystalline material of phloretin (light gray).
[0016] Figure 7 shows a comparison of the release kinetics of phloretin from the 303DS02 solid dispersion with bamboo silica extract as support (dark gray) and from the 302DS01 solid dispersion with synthetic amorphous mesoporous silica (OSI100) as support (light gray).
[0017] Figure 8 shows the X-ray reflections of transresveratrol (>98%) extracted from the root of Polygonum cuspidatum.
[0018] Figure 9 shows a comparison of the X-ray reflections of 303DS06 (dark gray) and the physical mixture between the pure crystalline trans-resveratrol material and the bamboo silica extract (light gray).
[0019] Figure 10 shows a comparison of the release kinetics of trans-resveratrol from 303DS06 (light gray) and pure crystalline trans-resveratrol materials (dark gray).
[0020] Figure 11 shows a comparison of the kinetics of Petition 870260002279, dated 09 / 01 / 2026, page 11 / 67 4 / 49 release of trans-resveratrol from solid dispersion 303DS06 with bamboo silica extract as carrier (light gray) and from solid dispersion 303DS05 with synthetic amorphous mesoporous silica (OSI100) as carrier (dark gray).
[0021] Figure 12 shows the amount of dissolved Si after 6 (left) and 8 (right) hours in FaSSIF at 37 °C from compositions A (black), B (dark gray), C, D and E (light gray) (from left to right).
[0022] Figure 13 shows the dissolution kinetics of composition F in ultrapure water at a temperature ranging from 23 to 60 °C.
[0023] Figure 14 shows the evolution of Si content for composition F in ultrapure water as a function of temperature.
[0024] Figure 15 shows the amount of silicon (mg) dissolved in FaSSIF at 37 °C after 8 hours as a function of grinding time in a ball mill.
[0025] Figure 16 shows the amount of silicon (mg) dissolved in FaSSIF at 37 °C after 8 hours as a function of the BPR ratio under the grinding conditions mentioned above.
[0026] Figure 17 shows the average particle size as a function of the BPR ratio.
[0027] Figure 18 shows the amount of silicon (mg) dissolved in FaSSiF at 37 °C after 8 hours, as a function of grinding time (h). DETAILED DESCRIPTION OF THE INVENTION
[0028] The present invention relates to a composition, more particularly an artificial composition, comprising a bamboo silica extract and a biologically active compound. The present invention further relates to a composition comprising bamboo silica extract, wherein said composition exhibits an enhanced silicon dissolution rate.
[0029] The inventors of the present application have demonstrated that the bioavailability of the biologically active compound with a bamboo silica extract as carrier is surprisingly comparable to that of a composition comprising the biologically active compound with synthetic mesoporous silica. Petition 870260002279, dated 09 / 01 / 2026, page 12 / 67 5 / 49 as a support. Interestingly, the use of bamboo silica extract enables a simpler and more ecological procedure for obtaining compositions containing mesoporous silica that stimulate the bioavailability of biologically active compounds.
[0030] Unless otherwise defined, all terms used in the disclosure of the invention, including technical and scientific terms, have the meaning as commonly understood by one skilled in the art to which this invention pertains. By way of further guidance, definitions of terms are included to better appreciate the teachings of the present invention.
[0031] As used in this document, the following terms have the following meanings:
[0032] Based on IUPAC recommendations for the characterization of porous solids, porous materials are classified according to the diameter of their pores. Pore diameter is defined as the average distance between the pore walls. This classification does not contain any information about pore morphology, such as geometry, orientation, pore interconnectivity, etc. The classification of porous materials, according to IUPAC, is as follows: microporous (< 2 nm), mesoporous (2 to 50 nm) and macroporous (> 50 nm) (Loni 2014 Springer International Publishing Switzerland).
[0033] The terms “a”, “an”, and “the”, as used in this document, refer to singular and plural referents unless the context clearly indicates otherwise. For example, “a compartment” refers to one or more than one compartment.
[0034] About, as used in this document, referring to a measurable value, such as a parameter, a quantity, a time duration and the like, is intended to cover variations of + / - 20% or less, preferably + / - 10% or less, more preferably + / - 5% or less, even more preferably + / - 1% or less, and even more preferably + / - 0.1% or less from the specified value, to the extent that such variations are appropriate for carrying out the disclosed invention. However, it should be understood Petition 870260002279, dated 09 / 01 / 2026, page 13 / 67 6 / 49 that the value to which the modifier “about” refers is also specifically disclosed.
[0035] “Compreendem”, “compreendendo” and “compreende” and “composto por”, as used in this document, are synonyms of “incluem”, including, “inclui” or “contêm”, “contém”, “contém” and are inclusive or open terms that specify the presence of what follows, for example component, and do not exclude or preclude the presence of additional components, features, elements, members, steps not mentioned, known in the art or disclosed in the art.
[0036] Furthermore, the terms first, second, third and the like in the description and claims are used to distinguish between similar elements and not necessarily to describe a sequential or chronological order, unless specified. It should be understood that the terms thus used are interchangeable under appropriate circumstances and that the embodiments of the invention described herein are capable of operating in sequences other than those described or illustrated in this document.
[0037] The recitation of numerical intervals by periods includes all numbers and fractions included within that interval, as well as the recited periods.
[0038] The expression “% by weight”, “percentage by weight”, “% by weight” or “% by weight / weight”, here and throughout the description, unless otherwise indicated, refers to the relative weight of the respective component based on the total weight of the formulation.
[0039] Considering that the terms “one or more” or “at least one”, such as one or more or at least one member(s) of a group of members, are self-evident, by way of further exemplification, the term includes, among others, a reference to any of said members, or to any two or more of said members, such as, for example, any >3, >4, >5, >6 or >7 etc. of said members, and even all of said members.
[0040] Unless otherwise defined, all Petition 870260002279, dated 09 / 01 / 2026, p. 14 / 67 7 / 49 Terms used in the disclosure of the invention, including technical and scientific terms, have the meaning as commonly understood by one skilled in the art to which this invention pertains. By way of further guidance, definitions are included for the terms used in the description to better appreciate the teaching of the present invention. The terms or definitions used herein are provided solely to assist in understanding the invention.
[0041] Any reference in this descriptive report to “an embodiment” means that a particular feature, structure, or characteristic described in conjunction with the embodiment is included in at least one embodiment of the present invention. Thus, occurrences of the phrase “in an embodiment” in various parts throughout this descriptive report are not necessarily all referring to the same embodiment, but may be. Furthermore, specific features, structures, or characteristics may be combined in any suitable manner, as would be evident to one skilled in the art from this disclosure, in one or more embodiments. Moreover, although some embodiments described herein include some, but not other, features included in other embodiments, combinations of features from different embodiments must be within the scope of the invention and form different embodiments, as will be understood by those skilled in the art.For example, in the following claims, any of the claimed embodiments may be used in any combination.
[0042] In a first aspect, the invention relates to a composition. More specifically, an artificial or non-natural composition. The composition comprises a bamboo silica extract and a compound, more specifically a biologically active compound. In another embodiment, the composition is provided in which the ratio of the total amount of the compound to the bamboo silica extract by weight is between 30 / 70 and 80 / 20, or between 10 / 90 and 50 / 50, preferably between 20 / 80 and 40 / 60 or between 25 / 75 and 35 / 65, even more preferably around 30 / 70. In another embodiment, the total amount of the (biologically active) compound naturally present in the bamboo silica extract is less than 10% by weight, less than 5% by weight, less than 2% by weight, less than 1% by weight, Petition 870260002279, dated 09 / 01 / 2026, page 15 / 67 8 / 49 less than 0.5% by weight or less than 0.1% by weight of the total weight of the bamboo silica extract. Thus, throughout the present application, the composition is always a chimeric or non-natural composition, comprising a bamboo silica extract and a (biologically active) compound, wherein the (biologically active) compound is wholly or partially added to the bamboo silica extract.
[0043] In a preferred embodiment, the biologically active compound is not naturally present in the bamboo silica extract, more specifically, the compound is derived from a source other than bamboo.
[0044] In a preferred embodiment of the invention, said bamboo silica extract comprises mesoporous silica in an amount of at least 60% by weight, more particularly comprising at least 70% by weight, at least 71% by weight, at least 72% by weight, at least 73% by weight, at least 74% by weight or at least 75% by weight of mesoporous silica, relative to the total weight of the bamboo silica extract.
[0045] In another embodiment, the application also provides a composition comprising bio-based or bio-derived mesoporous silica and a compound. Bio-based or bio-derived mesoporous silica, as used in this document, refers to mesoporous silica obtained from a biological source, for example, an extract from a plant or algae, more particularly obtained from bamboo, and even more preferably from the stem, leaves or young shoots of bamboo. Preferably, the silica is extracted from the leaves or young shoots of bamboo.
[0046] In another or a further embodiment, the composition of the invention comprises mesoporous silica, derived from a bamboo silica extract, in an amount of at least 30% by weight, at least 35% by weight, at least 40% by weight, at least 45% by weight, at least 50% by weight or at least 55% by weight, relative to the total weight of said composition, preferably around 49% by weight, around 50% by weight, around 51% by weight, around 52% by weight or around 53% by weight, more preferably in an amount between 48% and 54% by weight, or between 50% and 53% by weight. Petition 870260002279, dated 09 / 01 / 2026, page 16 / 67 9 / 49 by weight in relation to the total weight of the composition.
[0047] The bio-based mesoporous silica or the mesoporous silica present in the bamboo silica extract of the invention preferably has a specific surface area, calculated from nitrogen adsorption isotherms at liquid nitrogen temperature (77K) using the Brunauer, Emmett and Teller (BET) theory, of at least 250 m² / g, preferably at least 300 m² / g, more preferably at least 325 m² / g, at least 350 m² / g, at least 375 m² / g, at least 400 m² / g, at least 425 m² / g, at least 450 m² / g, at least 475 m² / g, at least 500 m² / g, at least 525 m² / g, at least 550 m2 / g, at least 575 m2 / g, at least 600 m2 / g, at least 625 m2 / g. m2 / g, at least 650 m2 / g, at least 675 m2 / g, at least 700 m2 / g, at least 725 m2 / g, at least 750 m2 / g, at least 775 m2 / g, at least 800 m2 / g.
[0048] Preferably, the specific surface area should be between 300 m2 / g and 900 m2 / g, or between 300 m2 / g and 800 m2 / g, or between 300 m2 / g and 700 m2 / g, or between 300 m2 / g and 650 m2 / g, or between 300 m2 / g and 600 m2 / g, or between 300 m2 / g and 500 m2 / g, or between 300 m2 / g and 450 m2 / g, or between 350 m2 / g and 450 m2 / g, or between 375 m2 / g and 425 m2 / g. The inventors surprisingly discovered that this specific surface area results in a similar release of a (biologically active) compound when dissolved in water, compared to that of a synthetic amorphous mesoporous silica (purity >99%; OSI100) with a significantly larger specific surface area of 680 m2 / g and the same content of the (biologically active) compound.
[0049] In another embodiment, the bio-based mesoporous silica or the mesoporous silica present in the bamboo silica extract of the invention has mesopores with an average pore size of at least 3 nm. The pore size was calculated from nitrogen adsorption isotherms at liquid nitrogen temperature (77K), according to the Barrett, Joyner and Halenda (BJH) method. The size of the mesopores of mesoporous bamboo silica, determined from the nitrogen sorption isotherm at 77 K, is 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30 nm. Petition 870260002279, dated 09 / 01 / 2026, page 17 / 67 10 / 49 or any value between the values above.
[0050] In a specific embodiment, the average pore size, calculated from nitrogen sorption isotherms at liquid nitrogen temperature (77K), according to the Barrett, Joyner and Halenda (BJH) method, is between 3 and 30 nm, preferably between 3.5 and 20 nm, preferably between 4 and 15 nm, preferably between 4.5 and 12 nm, or preferably between 5 and 11 nm. In a specific embodiment, the mesopores of the mesoporous silica present in the bamboo silica extract of the invention exhibit a distribution centered around 7 nm, around 7.5 nm, around 8 nm, around 8.5 nm, around 9 nm, around 9.5 nm, or around 10 nm. In a preferred embodiment, this distribution is centered around 8.5 nm.
[0051] In another embodiment, the bio-based mesoporous silica or the mesoporous silica present in the bamboo silica extract of the invention has an average pore volume or pore volume of at least 0.1 cm3 / g. In a preferred embodiment, the pore volume of the silica was calculated from nitrogen sorption isotherms at liquid nitrogen temperature (77K) by the Barrett, Joyner and Halenda (BJH) method. The pore volume mentioned is at least 0.1 cm3 / g, 0.2 cm3 / g, 0.4 cm3 / g, 0.5 cm3 / g, at least 0.6 m3 / g or at least 0.7 m3 / g, or any value between the above values. In a preferred embodiment, the pore volume is around 0.7 m3 / g.
[0052] In another embodiment, the bamboo silica extract of the invention comprises particles that separate into two size distributions, more particularly into a size distribution centered around 7 pm and a size distribution centered around 120 pm, determined by a particle size analyzer using the Beckman Coulter method in water at room temperature.
[0053] In another embodiment, the bamboo silica extract of the invention comprises particles with an average particle size (d50), determined by the Beckman Coulter method in water at room temperature, less than 150 pm, less than 125 pm, less than 100 pm, less than 75 pm, less than 50 Petition 870260002279, dated 09 / 01 / 2026, page 18 / 67 11 / 49 pm, less than 25 pm or less than 15 pm. In another embodiment, the bamboo silica extract of the invention comprises particles with an average particle size (d50), determined by the Beckman Coulter method in water at room temperature, between 15 and 150 pm, more particularly between 15 and 120 pm, and even more particularly around 100 pm.
[0054] In another embodiment, the bamboo silica extract of the invention comprises particles characterized by a d10 between 5 and 30 pm, as determined by the Beckman Coulter method in water at room temperature, or between 10 and 30 pm, and more particularly around 20 pm.
[0055] In another embodiment, the bamboo silica extract of the invention comprises particles characterized by a d25 between 20 and 100 pm, determined by the Beckman Coulter method in water at room temperature, or between 50 and 80 pm, and more particularly around 70 pm.
[0056] In another embodiment, the bamboo silica extract of the invention comprises particles characterized by a d75 between 100 and 200 pm, determined by the Beckman Coulter method in water at room temperature, or between 125 and 175 pm, and more particularly around 145 pm.
[0057] In another embodiment, the bamboo silica extract of the invention comprises particles characterized by a d90 between 100 and 200 pm, determined by the Beckman Coulter method in water at room temperature, or between 150 and 185 pm, and more particularly around 180 pm.
[0058] In another embodiment, the particle size distribution of bamboo silica extract is characterized by a d10 less than 30 pm; d25 less than 100 pm; d50 less than 125 pm; d75 less than 150 pm and d90 less than 200 pm, wherein the particle sizes are determined by the Beckman Coulter method in water at room temperature.
[0059] Smaller particles result in significantly higher dissolution rates. Without adhering to theory, it is presumed that this effect may be caused by a significant increase in surface area, a decrease in surface tension, and a consequent reduction in crystal formation. Petition 870260002279, dated 09 / 01 / 2026, page 19 / 67 12 / 49 and in the energy of the crystalline lattice.
[0060] In the current application examples, it is demonstrated that ball milling of the silica extract significantly reduces the particle size and that this reduction in particle size leads, for example, to an increase in the bioavailability of silicon or the compound that is physically mixed with the bamboo silica extract. Therefore, the composition described in this document is provided in which the bamboo silica extract comprises particles with an average particle size (d50), determined by the Beckman Coulter method in water at room temperature, between 5 and 25 pm, more particularly between 10 and 20 pm, and even more particularly around 15 pm.
[0061] In another embodiment, the particles are characterized by a d10 between 1 and 5 pm, determined by the Beckman Coulter method in water at room temperature, or between 2 and 4 pm, and more particularly around 3 pm. In another embodiment, the particles are characterized by a d25 between 2 and 10 pm, determined by the Beckman Coulter method in water at room temperature, or between 4 and 8 pm, and more particularly around 6 pm. In another embodiment, the particles are characterized by a d75 between 15 and 50 pm, determined by the Beckman Coulter method in water at room temperature, or between 20 and 40 pm, and more particularly around 30 pm. In another embodiment, the particles are characterized by a d90 between 60 and 100 pm, determined by the Beckman Coulter method in water at room temperature, or between 70 and 90 pm, and more particularly around 80 pm.In an additional embodiment, the particles are characterized by a d10 of at most 5 pm, a d25 of at most 10 pm, a d50 of at most 20 pm, a d75 of at most 40 pm and / or a d90 of at most 100 pm, wherein the particle sizes are determined by the Beckman Coulter method in water at room temperature.
[0062] The (biologically active) compound can be obtained and purified from nature or it can be synthesized. In one specific embodiment, the (biologically active) compound is a polyphenol. In another embodiment, the (biologically active) compound is an antioxidant. Petition 870260002279, dated 09 / 01 / 2026, p. 20 / 67 13 / 49
[0063] The term “antioxidant,” as used in this document, refers to a molecule that has the ability to neutralize free radicals in the body. Free radicals are molecules with an unpaired electron, which makes them highly reactive and capable of causing damage to the body’s cells and DNA. Antioxidants work by donating an electron to a free radical, which stabilizes the radical and prevents it from causing damage to other molecules. This process of donating an electron to neutralize a free radical is called oxidation, and antioxidants are so named because they prevent or slow down the oxidation of other molecules.
[0064] In another embodiment, the (biologically active) compound is selected from a list consisting of antioxidants, polyphenols, minerals, vitamins, provitamins, enzymes, probiotic bacteria, prebiotics, nutraceuticals, amino acids, algae extracts, and plant extracts. Non-limiting examples of vitamins are vitamin C and vitamin E. A non-limiting example of a provitamin is beta-carotene, which is converted into a vitamin (in this case, vitamin A) after being absorbed by the body.
[0065] Non-limiting examples of polyphenols include phloretin, phloretin derivatives such as glycosylated phloretin, resveratrol, trans-resveratrol, ellagic acid, curcumin, hydroxytyrosol, isoflavones or flavonoids such as quercetin, catechin, epicatechin or anthocyanin.
[0066] “Floretina”, as used herein, refers to dihydrochalcone with CAS number 60-82-2 and IUPAC name 3-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-propan-1-one.
[0067] Resveratrol is a natural compound found in certain plants, particularly in the skins of red grapes, blueberries, cranberries, and peanuts. It belongs to a class of compounds called polyphenols, known for their antioxidant properties. Studies suggest that resveratrol may have several potential health benefits. Studies have shown that resveratrol reduces inflammation in the body, which is believed to be a contributing factor to many chronic diseases, including cancer, diabetes, and heart disease. Resveratrol Petition 870260002279, dated 09 / 01 / 2026, page 21 / 67 14 / 49 has also been shown to have a positive effect on heart health, reducing the risk of heart disease, lowering blood pressure, and improving cholesterol levels. Furthermore, resveratrol has anti-aging effects, as it has been shown to activate genes linked to longevity and may help slow the aging process. Some studies suggest that resveratrol may have anticancer properties, inhibiting the growth of cancerous cells and promoting their death.
[0068] “Trans-resveratrol” is a specific form of resveratrol found in nature and considered the most biologically active form of the compound. Trans-resveratrol is more stable and more easily absorbed than cis-resveratrol, meaning it is less likely to degrade or break down over time and will be better utilized by the body when ingested as a supplement.
[0069] In a specific embodiment, the (biologically active) compound may be a natural extract or obtained from natural extracts. In a specific embodiment, the (biologically active) compound is phloretin derived from apple trees (Malus, preferably Malus pumila), strawberry plants (Fragaria), or apricot trees (Prunus, preferably Prunus mandshurica). In a further preferred embodiment, phloretin is produced from the leaves, bark, or root of a fruit-bearing plant, preferably the fruit-bearing plants mentioned above. Preferably, the root of a fruit-bearing plant, in particular the root of Malus pumila. The root of Malus pumila contains a relatively high concentration of phloretin. More importantly, it can be effectively purified to obtain a high-purity phloretin extract. One of the advantages of naturally derived phloretin is that it is ecologically beneficial.Naturally sourced phloretin extracts generally comprise a mixture of phloretin and glycosylated phloretin. Glycosylated phloretin can be converted to phloretin by hydrolysis, such as enzymatic hydrolysis or acid hydrolysis. Enzymatic hydrolysis provides ecological benefits. Acid hydrolysis can provide higher conversion and product purity. Petition 870260002279, dated 09 / 01 / 2026, page 22 / 67 15 / 49
[0070] The phloretin derivative is preferably a glycosylated phloretin. In a further preferred embodiment, the glycosylated phloretin is chosen from the list consisting of: phlorizin, phloretin 3',5'-di-C-glucoside and naringin dihydrochalcone. In a still more preferred embodiment, the glycosylated phloretin is phlorizin.
[0071] A “glycoside” is a molecule in which a sugar is linked to another functional group by means of a glycosidic bond. Formally, a glycoside is any molecule in which a sugar group is linked, through its anomeric carbon, to another group by means of a glycosidic bond. Glycosides can be linked by an O- (an O-glycoside), N- (a glycosylamine), S- (a thioglycoside) or C- (a C-glycoside) glycosidic bond. According to IUPAC, the name C-glycoside is a misnomer; the preferred term is “C-glycosylated compound”. Preferably, the sugar should be linked to a non-sugar substance for the molecule to be classified as a glycoside, thus excluding polysaccharides. The sugar group is then known as the glycone and the non-sugar group as the aglycone or genin part of the glycoside. A glycone can be composed of a single sugar group (monosaccharide) or several sugar groups (disaccharide or oligosaccharide).
[0072] “Glycosylated phloretin” and “phloretin glycoside,” as used in this document, are synonyms and refer to a molecule in which one or more sugars are linked to one or more functional groups of a phloretin molecule by means of a glycosidic linkage. The glycosides may be linked by an O-glycoside or C-glycoside linkage. The sugar is preferably a monosaccharide or a disaccharide. Preferably, one or more sugars are glucose.
[0073] “Florizina”, as used herein, refers to a phloretin glycoside with CAS number 60-81-1 and IUPAC name 1-(2,4-Dihydroxy-6{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(4-hydroxyphenyl)propan-1-one.
[0074] In another specific form, the compound Petition 870260002279, dated 09 / 01 / 2026, page 23 / 67 16 / 49 (biologically active) can be a natural extract, more particularly a plant or seaweed extract, and even more particularly a seaweed extract, and even more particularly a seaweed extract rich in calcium and magnesium. A non-limiting example of seaweed is a calcareous seaweed of the genus Lithothamnion.
[0075] In a further specific embodiment, the seaweed extract, more particularly the seaweed extract, comprises at least 15%, at least 20%, at least 25% and at least 30% calcium. In another specific embodiment, the seaweed extract, more particularly the seaweed extract, comprises at least 1%, at least 1.5% and at least 2% magnesium. In a further specific embodiment, the seaweed extract, more particularly the seaweed extract, comprises at least 25% calcium and 1.5% magnesium or at least 30% calcium and 2% magnesium.
[0076] The inventors have surprisingly discovered that the addition of seaweed extract dramatically increases the dissolution rate of mesoporous silica present in bamboo silica extract, allowing the composition to provide bioavailable silicon. In another embodiment, the composition provided herein comprises a seaweed extract or the mineral derived therefrom and bamboo silica extract, as described in this document, wherein the seaweed extract (or the mineral derived therefrom) and the bamboo extract are present in a ratio of 40:60 to 80:20.
[0077] In another preferred embodiment, mesoporous silica present in bamboo silica extract, preferably in combination with minerals or algae extract, is added to water and subsequently heated to an elevated temperature. Preferably, the elevated temperature is between 50 and 99 °C, more preferably between 60 and 99 °C, more preferably between 65 and 95 °C, and most preferably between 70 and 90 °C. The elevated temperature improves the dissolution kinetics as well as the solubility balance, favoring bioavailable silicon species relative to silica when compared to room temperature. Furthermore, the inventors have surprisingly discovered, Petition 870260002279, dated 09 / 01 / 2026, page 24 / 67 17 / 49 that the addition of minerals, particularly calcium and magnesium ions (Ca2+ and Mg2+), limits the formation of silica gel during cooling. Consequently, an aqueous solution with a higher content of bioavailable silicon is obtained. In a preferred embodiment, a supersaturated aqueous solution of silicon is obtained in the presence of minerals. As an additional benefit, the aqueous solution with a high content of bioavailable silicon can be produced in a biobased manner. The prevention of polymerization of (bioavailable) silicon compounds is usually achieved through the use of synthetic organosilicon compounds, often in combination with high amounts of stabilizers, such as alkylated silanol compounds. Carbon-silicon bonds are cleaved and absorbed more easily than silica networks. However, this implies the ingestion of synthetic organosilicon compounds, which are often new and relatively untested.
[0078] The (biologically active) compound can be impregnated or loaded onto the mesoporous silica present in bamboo silica extract in various ways. For example, one or more compounds can be deposited on the surface of silica particles, incorporated into the pores of porous silica, incorporated into pores formed by the agglomeration or consolidation of silica particles (particularly nanoparticles), or bound to or otherwise associated with the surface of bamboo silica. Suitable methods for incorporating bamboo silica into the compound include drum coating, fluidized bed, spray drying, spray cooling, encapsulation, dusting / coating, and co-extrusion techniques.
[0079] Higher loading levels, for example, at least about 15% by weight of the loaded compound based on the loaded weight of the bamboo silica extract, can be achieved by performing the impregnation at an elevated temperature. For example, loading can be carried out at a temperature equal to or greater than the melting point of the compound to be loaded. Quantification of the gross loading can be conveniently performed by several known analytical methods, including gravimetry, EDX (energy-dispersive X-ray analysis), and infrared spectroscopy. Petition 870260002279, dated 09 / 01 / 2026, page 25 / 67 Fourier transform infrared spectroscopy (FTIR), Raman spectroscopy, UV spectrophotometry, titrimetric analysis, HPLC, or mass spectrometry. If necessary, charge uniformity quantification can be obtained using techniques capable of spatial resolution, such as cross-sectional EDX, Auger depth profiling, micro-Raman, and micro-FTIR.
[0080] Loading levels can be determined by dividing the weight of the compound absorbed during loading (equivalent to the mass of the absorbed ingredient divided by its density) by the volume of voids in the porous bamboo silica before loading, multiplied by one hundred.
[0081] In a preferred embodiment of the invention, the composition is provided in which at least 60% by weight of one or more (biologically active) compounds dissolves in water after 2 hours at 37 °C. This means that when the composition of the present invention is placed in water at 37 °C, at least 60% by weight of one or more biologically active compounds dissolves in water after 2 hours. In a further preferred embodiment, at least 65% by weight, more preferably at least 70% by weight, more preferably at least 75% by weight, more preferably at least 80% by weight, more preferably at least 85% by weight, more preferably at least 90% by weight, more preferably at least 95% by weight of one or more biologically active compounds are dissolved in water after 2 hours at 37 °C. This high amount of the dissolved (biologically active) compound or compounds results in greater bioavailability.
[0082] In another preferred embodiment of the invention, the (biologically active) compound, which is impregnated in or on mesoporous silica, exhibits an X-ray diffraction crystallinity of at most 80%, preferably at most 70%, more preferably at most 50%, more preferably at most 35%, more preferably at most 25%, more preferably at most 15%, more preferably at most 60%, more preferably at most 40%, more preferably at most 30%, more preferably at most 20%, more preferably at most 10%, more Petition 870260002279, dated 09 / 01 / 2026, page 26 / 67 19 / 49 preferably at most 8%, more preferably at most 7%, more preferably at most 6%, and most preferably at most 5%.
[0083] The degree of crystallinity of the samples can be determined by the X-ray diffraction method, as described below. The inventors found that a lower crystallinity measured by X-ray diffraction was associated with a significant increase in the dissolution rate.
[0084] In another preferred embodiment, the compound present in the composition is a salt or the composition further comprises a salt. Said salt consists of a cation and an anion, wherein said salt is chosen from the list of alkali metal salts, alkaline earth metal salts or a mixture thereof. Preferably, the salt is chosen from the list of magnesium salts, calcium salts, potassium salts, sodium salts or a mixture thereof, more preferably magnesium salts or calcium salts, and most preferably calcium salts. Preferably, said salt is an organic salt, preferably acetate, citrate, tartrate, formate, benzoate, gluconate, sorbate or a mixture thereof. Preferably, the salt in question is calcium acetate. Preferably, the salt in question is edible; more preferably, it is acceptable for pharmaceutical use.Preferably, the weight ratio of the cation of said salt to the bamboo silica extract is between 1:100 and 200:100, preferably between 10:100 and 200:100, more preferably between 50:100 and 150:100, and even more preferably between 40:60 and 80:20. The inventors surprisingly discovered that the addition of these salts, more particularly the salts present in an algae extract, presumably due to the stabilizing effects of silicic acids such as orthosilicic acid associated with cations dissolved in aqueous medium, drastically increases the dissolution rate of mesoporous silica present in the bamboo silica extract. This advantageously allows the composition to provide bioavailable compounds as well as bioavailable silicon. Furthermore, the dissolution of mesoporous silica from bamboo silica extract aids in the dissolution of particles of the biologically active compound.
[0085] In another embodiment, the silica extract of Petition 870260002279, dated 09 / 01 / 2026, page 27 / 67 The 20 / 49 bamboo present in the compositions provided here is an extract of young bamboo leaves. The term "young," as used in this document, refers to leaves aged between 1 and 10 days, or between 5 and 14 days, or between 2 and 20 days. In another specific embodiment, the leaves are less than 100 days old, less than 80 days old, less than 60 days old, less than 40 days old, less than 21 days old, or less than 15 days old.
[0086] In another additional embodiment, bamboo silica extract is a silica extract from the leaves of Bambusa arundinaceae. A non-limiting example of a process for obtaining this extract comprises a step of collecting young bamboo leaves, a step of washing and drying the bamboo leaves, a step of grinding the dried bamboo leaves into powder and, optionally, a step of treating the bamboo powder with a base to remove lignin and hemicellulose.
[0087] In a second aspect, the present invention provides an oral pharmaceutical form comprising any of the compositions according to the first aspect or described in this document.
[0088] In a preferred embodiment, said oral pharmaceutical form is a solid oral pharmaceutical form, such as a tablet or a powder, and more preferably said solid oral pharmaceutical form is a tablet. To facilitate dissolution, the tablet should preferably not receive any additional coating.
[0089] The inventors discovered that the composition, according to the first aspect, is especially advantageous as an oral pharmaceutical form, as it improves the bioavailability and, consequently, the absorption of one or more (biologically active) compounds present in the composition. In particular, these effects are more pronounced in the gastrointestinal tract.
[0090] In a preferred embodiment, the present invention provides an oral pharmaceutical form comprising said composition in an amount of at least 1% by weight, relative to the total weight of said oral pharmaceutical form, preferably at least 10% by weight, preferably at least 25% by weight, preferably at least 50% by weight. Petition 870260002279, dated 09 / 01 / 2026, page 28 / 67 21 / 49 weight, preferably at least 80% by weight.
[0091] A higher percentage of the composition, according to the invention, allows for a greater concentration of silica and the (biologically active) compound to be administered into the individual's gastrointestinal tract, thus enabling better absorption by the human or animal organism.
[0092] As described above, bamboo mesoporous silica increases the bioavailability of a compound that is carried on the silica particle, particularly when the particle size of the compound is reduced and the compound is carried primarily in an amorphous state. In this context, silica acts beneficially as a stabilizer for small, amorphous particles. This is particularly useful when the compound is a medicine or has beneficial health effects. Therefore, in a third aspect, any compositions or oral dosage forms disclosed herein are provided for use as a medicine or for use in the prevention or treatment of a disease. This is equivalent to saying that treatment methods are provided for an individual, in which any of the compositions or any of the oral dosage forms disclosed herein are administered to an individual in need of them.
[0093] For example, dihydrochalcone phloretin is capable of accelerating remyelination. In particular, phloretin is able to stimulate the maturation of OPCs in in vitro OPC cultures and improve (re)myelination in ex vivo demyelinated brain slices with microglia depletion. Furthermore, it has been demonstrated here that phloretin is capable of inducing OPC differentiation through PPARγ activation. Due to these effects on remyelination and on oligodendrocyte differentiation and maturation, the present application provides, in a further embodiment, a composition according to the first aspect or an oral pharmaceutical form according to the second aspect for use in the treatment or prevention of a neurological disease, more particularly a demyelinating disease.
[0094] As used in this document, the term “demyelinating disease” refers to a pathological condition in which the myelin sheath that Petition 870260002279, dated 09 / 01 / 2026, page 29 / 67 22 / 49 involving neurons in nervous tissue is lost or damaged, leading to axonal degeneration and impaired signal transduction in the affected nerves. A demyelinating disease of the central nervous system is a disease in which the myelin sheaths of neurons in the central nervous system are lost or damaged. Examples of demyelinating diseases of the central nervous system include multiple sclerosis, neuromyelitis optica (Devic's disease), inflammatory demyelinating diseases, central nervous system neuropathy, central pontine myelinolysis, myelopathy, leukoencephalopathy, or leukodystrophy.
[0095] A demyelinating disease of the peripheral nervous system is a pathological condition in which the myelin sheaths of neurons in the peripheral nervous system are lost or damaged. Examples of demyelinating diseases of the peripheral nervous system include Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, anti-MAG peripheral neuropathy, Charcot-Marie-Tooth disease, hereditary neuropathy with a predisposition to pressure paralysis; conditions associated with copper deficiency, such as peripheral neuropathy, myelopathy, optic neuropathy; progressive inflammatory neuropathy, diabetic neuropathy, or traumatic nerve injury. In another preferred embodiment of the third aspect, the invention relates to a composition according to the first aspect or to an oral pharmaceutical form according to the second aspect for providing neuroprotective effects.
[0096] Other compounds may be useful in the treatment or prevention of other diseases. Therefore, in another embodiment of the third aspect, the composition disclosed here is intended for the treatment or prevention of inflammatory diseases, cancer, neurological diseases, neurodegenerative diseases, cardiovascular diseases, metabolic disorders, skin diseases, liver diseases, bone diseases, estrogen deficiency, estrogen deficiency-induced osteoclastogenic resorption, obesity, cardiomyopathy and demyelinating diseases.
[0097] Non-limiting examples of neurodegenerative diseases include Alzheimer's disease, dementia, multiple sclerosis, Petition 870260002279, dated 09 / 01 / 2026, page 30 / 67 23 / 49 Parkinson's disease, ALS, Charcot-Marie-Tooth disease, Huntington's disease, multiple system atrophy, traumatic nerve injury, diabetic neuropathy, chronic inflammatory polyradiculoneuropathy, and Guillain-Barré syndrome.
[0098] Non-exhaustive examples of skin diseases include those related to skin health and well-being, such as skin aging, hyperpigmentation, acne, and skin cancer.
[0099] The individual can be a non-human animal or a human being. Preferably, the subject is a human being.
[0100] In a fourth aspect, the use of bio-based mesoporous silica is presented to increase the bioavailability of a compound. The term “bio-based,” as used in this document, refers to “biologically derived,” “of biological origin,” or “bio-based” and means that the mesoporous silica is obtained, extracted, or derived from a biological source, such as a plant.
[0101] In a particular embodiment, bio-based mesoporous silica is silica obtained or extracted from bamboo, more particularly a bamboo silica extract, and even more particularly a bamboo silica extract comprising at least 70% mesoporous silica.
[0102] A method is also presented for improving the bioavailability of a compound, such as a biologically active substance, comprising the following steps:
[0103] - provide bio-based mesoporous silica;
[0104] - load the mesoporous silica from the bamboo silica extract with the compound;
[0105] - administer loaded mesoporous silica to an individual in need of it;
[0106] in which the bioavailability of the compound is increased compared to administration of the biologically active compound alone.
[0107] The preferred composition modalities are in accordance with the first and sixth aspects described in this document; and are Petition 870260002279, dated 09 / 01 / 2026, page 31 / 67 24 / 49 produced using their respective methods. The inventors discovered that by decreasing the particle size of the compound, more particularly the biologically active compound, during impregnation or physical mixing in mesoporous silica, the dissolution rate in water increased significantly. This higher dissolution rate results in greater bioavailability and, primarily, greater absorption of the biologically active compound in the gastrointestinal tract.
[0108] In one specific embodiment, the loading consists of the physical mixing of mesoporous silica with the compound. In another embodiment, the physical mixing comprises grinding, for example, grinding in a ball mill or hammer mill, of the silica with the compound.
[0109] The mesoporous silica mentioned in the use and method described above for improving the bioavailability of a compound may be any mesoporous silica as described in the first aspect.
[0110] In another preferred embodiment of the invention, the method comprises the following steps:
[0111] i. provide a bio-based mesoporous silica, preferably with a specific surface area, calculated from nitrogen sorption isotherms at liquid nitrogen temperature (77K) using the Brunauer, Emmett and Teller (BET) theory, of at least 250 m2 / g;
[0112] ii. provide a compound that exhibits a first crystallinity by X-ray diffraction, determined by X-ray diffraction and by Segal's formula;
[0113] iii. impregnate or physically mix mesoporous silica with the compound, wherein the compound exhibits a second XRD crystallinity, determined by X-ray diffraction and Segal formula, lower than the first XRD crystallinity.
[0114] In this embodiment of the invention, the ratio between the crystallinity of the first X-ray diffraction and the crystallinity of the second X-ray diffraction is at least 1.25, preferably at least 1.5, and more preferably at least 2. Petition 870260002279, dated 09 / 01 / 2026, page 32 / 67 25 / 49
[0115] In another embodiment of the invention, the first X-ray diffraction crystallinity, determined using X-ray diffraction and Segal's formula, of the compound is between 70 and 100%, preferably between 80 and 100%, more preferably between 90 and 100%.
[0116] In another embodiment of the invention, the second crystallinity by X-ray diffraction, determined using X-ray diffraction and Segal's formula, of the compound is at most 70%, more preferably at most 60%, even more preferably at most 50% and, most preferably, at most 40%.
[0117] The inventors discovered that by decreasing the crystallinity of the compound during impregnation in mesoporous silica from bamboo silica extract, the dissolution rate in water increased significantly. This higher dissolution rate results in greater bioavailability and, primarily, greater absorption of the compound in the gastrointestinal tract. The more amorphous the compound, the better its dissolution in water. SIXTH AND SEVENTH ASPECTS
[0118] In a sixth aspect, the invention relates to a composition comprising a silica extract, wherein the composition exhibits improved silicon (Si) solubility. Silicon, and particularly silica, is difficult to dissolve or solubilize, polymerizing and precipitating readily from water. The present description aims to modify silica extracts derived from bamboo so that the dissolution kinetics are favored. This allows the production of bio-based silicon compositions with a high content of soluble and bioavailable silicon.
[0119] In one embodiment, the fifth aspect relates to a composition comprising a silica extract derived from bamboo, wherein said composition is characterized by a silicon (Si) dissolution of at least 3% by weight, more preferably at least 4% by weight, more preferably at least 5% by weight, more preferably at least 6% by weight, more preferably at least 7% by weight, more preferably at least 8% Petition 870260002279, dated 09 / 01 / 2026, page 33 / 67 26 / 49 by weight, more preferably at least 9% by weight, more preferably at least 10% by weight, more preferably at least 11% by weight, more preferably at least 12% by weight, more preferably at least 13% by weight, more preferably at least 14% by weight, more preferably at least 15% by weight relative to silicon in the composition, in FaSSIF after 8 hours at 37 °C, as measured by ICP-OES.
[0120] In one embodiment, said composition comprises silica SiO2 in an amount of at least 30% by weight, more preferably at least 40% by weight, more preferably at least 50% by weight, more preferably at least 60% by weight, more preferably at least 70% by weight, more preferably at least 80% by weight, more preferably at least 90% by weight, and most preferably consists essentially of silica. Preferably, the silica contained in said composition is of bio-based origin, more preferably derived from bamboo, and more preferably a bamboo silica extract. The present disclosure advantageously presents methods for significantly increasing the solubility of bamboo silica extracts without the need for chemical conversion, solvents or silicon precursors (organochemicals), as well as without the ecological problems associated with these practices.
[0121] In one embodiment, said composition has an average particle size of at least 0.001 pm, more preferably at least 0.005 pm, more preferably at least 0.01 pm, more preferably at least 0.05 pm, and most preferably at least 0.10 pm. In another embodiment, said composition has an average particle size of at most 15.00 pm, more preferably at most 10.00 pm, more preferably at most 5.00 pm, more preferably at most 3.00 pm, more preferably at most 2.00 pm, more preferably at most 1.00 pm, more preferably at most 0.80 pm, more preferably at most 0.60 pm, more preferably at most 0.50 pm, and most preferably at most 0.30 pm. In a preferred embodiment, said composition has a size Petition 870260002279, dated 09 / 01 / 2026, p. 34 / 67 27 / 49 average particle size between 0.05 and 1.00 µm, more preferably between 0.10 and 0.50 µm. The average particle size, d50, is measured by the Beckman Coulter method in water at room temperature.
[0122] In one embodiment, said composition has a specific surface area calculated from nitrogen sorption isotherms at liquid nitrogen temperature (77K) by the Brunauer, Emmett and Teller (BET) theory, of at most 600 m² / g, more preferably at most 500 m² / g, more preferably at most 400 m² / g, more preferably at most 350 m² / g, more preferably at most 300 m² / g, more preferably at most 250 m² / g, more preferably at most 200 m² / g, more preferably at most 150 m² / g. In a preferred embodiment, the specific surface area of the composition is between 50 and 400 m² / g, more preferably between 100 and 300 m² / g. Compositions with high specific surface area are normally easier to dissolve due to the large water-solid interface. However, obtaining bio-based silica, particularly bamboo-based silica, with a high specific surface area remains a challenge.Typically, chemical reforming is required. The inventors discovered that silica with low mesoporosity and low surface area can be solubilized. Furthermore, these methods further reduce the specific surface area, still resulting in high silicon solubility in the material.
[0123] In a preferred embodiment, the composition comprises silica in an amount of at least 50% by weight, has a particle size between 0.1 and 1.0 µm and a specific surface area between 100 and 300 m² / g. Preferably, the silica is entirely bio-based, most preferably extracted from bamboo. Preferably, the remainder of the composition should consist of plant-based impurities from bamboo. One advantage is that they do not need to be completely removed, reducing the purification requirements of the extraction and dramatically improving yields. Despite these limited purification and modification requirements, a composition with relatively high silicon solubility in FaSSIF is obtained. Petition 870260002279, dated 09 / 01 / 2026, page 35 / 67 28 / 49
[0124] In the seventh aspect, the present invention relates to a method for producing a soluble silica composition. In particular, the seventh aspect relates to a method for converting a silica extract, preferably a bio-based silica extract, into a composition with much higher silicon solubility and dissolution rate. In one embodiment, the method comprises the following steps:
[0125] - provide a grinding composition, wherein said composition comprises a silica extract derived from bamboo in an amount of at least 30% by weight in relation to the composition; and
[0126] - grinding in a ball mill of said grinding composition, thereby obtaining a soluble silica composition.
[0127] In one embodiment, ball milling is performed with a ball-to-powder ratio (BPR) of at least 2.5, more preferably at least 3.0, more preferably at least 3.5, more preferably at least 4.0, more preferably at least 4.5 and more preferably at least 5.5. In one embodiment, ball milling is performed with a ball-to-powder ratio (BPR) of at most 10.0, more preferably at most 8.0, more preferably at most 7.0, more preferably at most 6.5, more preferably at most 6.0 and, most preferably, at most 5.5. In one embodiment, ball milling is performed with a ball-to-powder ratio (BPR) between 3.5 and 7.0, more preferably between 4.5 and 6.0. The ratio between the spheres and the powder is determined as a weight-to-weight ratio of the grinding spheres to the grinding composition as a whole.Lower sphere-to-powder ratios result in insufficiently small particle sizes and / or significantly longer grinding times. Higher sphere-to-powder ratios are very inefficient in terms of energy.
[0128] Preferably, ball mill grinding should not be vibratory ball milling. Vibratory ball milling requires a lot of energy and offers little or no benefit. It is also not Petition 870260002279, dated 09 / 01 / 2026, page 36 / 67 29 / 49 suitable for large-scale production.
[0129] Ball milling is preferred over other milling mechanisms. Several other milling types, such as hammer milling, have been investigated. These methods have been found to be considerably less effective at solubilizing silicon from silica. While increases were possible, these required significantly more energy or the use of solvents and / or chemicals, thus eliminating the ecological benefits of current methods.
[0130] In one embodiment, the grinding time in a ball mill is at least 3.0 hours, more preferably at least 3.5 hours, more preferably at least 4.0 hours and, most preferably, at least 4.5 hours.
[0131] In one embodiment, the grinding time in a ball mill is at most 8.0 hours, more preferably at most 7.0 hours, more preferably at most 6.0 hours, more preferably at most 6.5 hours, more preferably at most 6.0 hours, more preferably at most 5.5 hours, and most preferably at most 5.0 hours. In another embodiment, the grinding time is between 3.0 and 8.0 hours, more preferably between 3.5 and 5.0 hours. Preferably, these grinding times in a ball mill are used in combination with the BPR ratios described above. The grinding times and preferred BPR ratios are optimized to maximize the dissolution rate depending on energy requirements. The dissolution rate can be increased further, but this entails an ever-increasing energy cost. Furthermore, beyond a certain point, the dissolution rate reaches a plateau, limiting additional gains.Furthermore, further increasing the BPR ratio may result in limited stability. Very small particles agglomerate towards larger particle sizes during storage and transport, minimizing the benefits of further increasing the fragmentation rate (BPR) and / or grinding time.
[0132] In a preferred embodiment, the mill RPM Petition 870260002279, dated 09 / 01 / 2026, p. 37 / 67 30 / 49 of spheres is at least 100, more preferably at least 200, more preferably at least 300, and most preferably at least 400. In a preferred embodiment, the RPM of the sphere mill is at most 1000, more preferably at most 800, more preferably at most 700, more preferably at most 600, and most preferably at most 500. Preferably, the RPM of the sphere mill should be between 300 and 600, more preferably between 400 and 500.
[0133] In one embodiment, the grinding composition has a specific surface area of at most 650 m2 / g, more preferably at most 600 m2 / g, more preferably at most 550 m2 / g, more preferably at most 500 m2 / g, more preferably at most 450 m2 / g, more preferably at most 400 m2 / g, more preferably at most 350 m2 / g, more preferably at most 300 m2 / g, more preferably at most 250 m2 / g. In one embodiment, the grinding composition has a specific surface area of at least 1 m² / g, more preferably at least 10 m² / g, more preferably at least 25 m² / g, more preferably at least 50 m² / g, more preferably at least 100 m² / g, more preferably at least 150 m² / g, and most preferably at least 200 m² / g. Preferably and advantageously, when grinding in a ball mill is carried out from compositions with a relatively smaller specific surface area, it is preferable.Grinding in a ball mill at the required intensity reduces the specific surface area. Production with a high specific surface area requires more energy and specific production requirements. Starting with compositions with a lower specific surface area avoids, or at least reduces, energy requirements and process complexity, with a limited impact on the solubility of the result. This is particularly desirable in the solubilization of bio-based products.
[0134] In one embodiment, the grinding composition has an average particle size d50 of at least 1.0 µm, more preferably at least 1.5 µm, more preferably at least 2.0 µm, more Petition 870260002279, dated 09 / 01 / 2026, page 38 / 67 31 / 49 preferably at least 2.5 pm, more preferably at least 3.0 pm, more preferably at least 3.5 pm, more preferably at least 4.5 pm, more preferably at least 5.0 pm, more preferably at least 7.5 pm, more preferably at least 10.0 pm, more preferably at least 12.5 pm, more preferably at least 15.0 pm, more preferably at least 20.0 pm, more preferably at least 25.0 pm, more preferably at least 50.0 pm. The average particle size is determined by the Beckman Coulter method in water at room temperature.
[0135] In a preferred embodiment, the method comprises the following steps:
[0136] - to provide a grinding composition, wherein said composition comprises a silica extract derived from bamboo in an amount of at least 30% by weight relative to the composition; wherein said grinding composition has an average particle size d50 of at least 2.5 µm and a specific surface area of less than 300 g / m2; and
[0137] - subjecting said grinding composition to grinding in a ball mill at a BPR weight ratio between 3.0 and 8.0, for a period between 3.0 and 8.0 hours, thereby obtaining a soluble silica composition.
[0138] In a specific preferred embodiment, the method comprises the following steps:
[0139] - provide an insoluble composition, wherein said composition comprises a silica extract derived from bamboo in an amount of at least 30% by weight relative to the composition; and
[0140] - measure the specific surface area calculated from nitrogen sorption isotherms at the temperature of liquid nitrogen (77K) by the Brunauer, Emmett and Teller (BET) theory of said insoluble composition;
[0141] - when the specific surface area of the insoluble composition is greater than 650 m2 / g, a salt, preferably a calcium salt, is added to the insoluble composition in an amount of at least 10% by weight relative to the weight of the silica extract; thus obtaining the silica composition. Petition 870260002279, dated 09 / 01 / 2026, page 39 / 67 32 / 49 soluble; and
[0142] - when the specific surface area of the insoluble composition is less than 650 m2 / g, this insoluble composition is subjected to grinding in a ball mill, thus obtaining the soluble silica composition.
[0143] The inventors have surprisingly discovered relatively inexpensive yet highly effective methods for solubilizing bio-based silica extracts with high and low specific surface areas. This allows for the solubilization of silica extracts in general, without being restricted, for example, to silicas with a high specific surface area. Furthermore, the methods do not require solvents or chemical reagents derived from fossil fuels. In this way, a bio-based and environmentally friendly silica composition with high silicon bioavailability can be obtained. In particular, the inventors found that alkaline salts, especially divalent salts, most preferably calcium salts, significantly improve the dissolution of mesoporous silica with a high specific surface area. However, the effect of calcium salts on silica without a high specific surface area is very limited.Silica, regardless of specific surface area, can be solubilized by ball milling until a dry dispersion with a relatively small particle size is obtained. This process reduces the specific surface area of the silica and consumes a lot of energy. Furthermore, producing structures that result in very high specific surface areas also requires large amounts of energy. Thus, ball milling is a more energy-efficient method for silicas with lower specific surface areas. This is particularly desirable because most bio-based silica extracts, regardless of specific growth and extraction conditions, as well as subsequent modifications, have a very low specific surface area for the addition of calcium salts to be sufficiently effective.
[0144] The preferred conditions for grinding in a ball mill are those described above.
[0145] In a preferred embodiment, salt is a salt Petition 870260002279, dated 09 / 01 / 2026, page 40 / 67 33 / 49 organic, preferably a magnesium or calcium salt, more preferably a calcium salt. Preferably, the salt in question is an acetate, citrate, tartrate, formate, benzoate, gluconate, sorbate, or a mixture thereof. Preferably, the salt in question is calcium acetate. In another preferred embodiment, the salt is a plant or algae extract. Preferably, the salt is a seaweed extract rich in calcium cations (Ca2+). A non-limiting example of seaweed is a calcareous seaweed of the genus Lithothamnion. One of the advantages is that this provides a bio-based source of calcium in combination with a bio-based source of silicon with high solubility.
[0146] The inventors have surprisingly discovered that the addition of seaweed extract dramatically increases the dissolution rate of mesoporous silica present in bamboo silica extract, which allows the composition to provide bioavailable silicon. In another embodiment, the composition provided herein comprises a seaweed extract or the mineral derived therefrom and bamboo silica extract, as described in this document, wherein the seaweed extract (or the mineral derived therefrom) and bamboo silica extract are present.
[0147] In another preferred embodiment, the soluble composition comprises silica to calcium salt, preferably calcium acetate or algae extract with calcium, in a ratio between 20:80 and 80:20, more preferably from 40:60 to 80:20, more preferably from 50:50 to 80:20, and even more preferably from 60:40 to 80:20 of silica to algae by weight.
[0148] The invention is further described by the following non-limiting examples which further illustrate the invention, and are not intended to, nor should they be construed as, limiting the scope of the invention. EXAMPLES EXAMPLE 1. A BAMBOO EXTRACT COMPOSED OF MESOPOROUS SILICA
[0149] Young shoots of Bambusa arundinacea were collected and used to make an extract. To our surprise, it was discovered that the bamboo silica extract is composed of a mesoporous material, more Petition 870260002279, dated 09 / 01 / 2026, page 41 / 67 34 / 49 specifically mesoporous silica. The mesoporosity of silica is demonstrated by the nitrogen physisorption curves in Figure 1. Interestingly, bamboo silica extract contains a very high amount of mesoporous silica, more specifically 76.5% relative to the total weight of the bamboo silica extract.
[0150] Specific surface area measurements of Brunauer, Emmett and Teller (BET) and the pore size distribution of bamboo silica extract were determined using a Micromeritics ASAP 2460 surface area and porosity analyzer at liquid nitrogen temperature (-198.8 °C or 77 K). Nitrogen was used as a gas analyzer.
[0151] Bamboo mesoporous silica extract is characterized by a high specific surface area of approximately 300 m² / g, determined from the amount of nitrogen adsorbed. Given that the organic compounds present in bamboo silica extract negatively influence the specific surface area of the material, since it is likely very low, the porosity of the mesoporous silica present in the bamboo extract is higher than measured. Considering a silica content of 75% in the material, the actual specific surface area of the mesoporous silica present in the bamboo extract is around 400 m² / g.
[0152] The pore volume of mesoporous silica, measured by the BJH desorption and adsorption method, was 0.70 cm3 / g.
[0153] The pore size distribution of the bamboo silica extract can be seen in Figure 2, which shows the pore volume dV / dW (cm3 / g) as a function of pore size (nm). As shown in Figure 2, the pore size distribution curve of the bamboo silica extract is centered at 8.5 nm.
[0154] The particle size distribution of bamboo silica extract was determined by a particle size analyzer using the Beckman Coulter method in water at room temperature. The particle size distribution in the volume of material obtained by this method can be seen in Figure 3. Two size distributions are observed, a minority distribution centered at 7 µm and a major distribution at approximately 120 µm. Petition 870260002279, dated 09 / 01 / 2026, page 42 / 67 35 / 49
[0155] The main parameters of the particle size distribution of this material are shown in Table 1. 10% of the particles have a size less than 27.2 pm (d10), 25% of the particles have a size less than 72 pm (d25), 50% of the particles have a size less than 107 pm (d50), 75% of the particles have a size less than 145 pm (d75) and 90% of the particles have a size less than 181 pm (d90). TABLE 1. MAIN DISTRIBUTION PARAMETERS OF THE PARTICLE SIZE BY VOLUME OF BAMBOO SILICA EXTRACT. d10 (pm) d25(pm) d50 (pm) d75 (pm) d90(pm) 27.2 72.0 107 145 181 EXAMPLE 2. HIGH PURITY APPLE EXTRACT (>95% PHLORETTIN)
[0156] Phloretin is extracted from the dried root bark of Malus pumila. Phloretin powder is a crystalline material, as demonstrated by the X-ray reflection in Figure 4, which shows the intensity (I) of the X-ray reflections of phloretin as a function of 2θ, where 2Θ is the angle between the incident ray and the reflected ray.
[0157] The characterization of the amorphous or crystalline state of phloretin was performed by X-ray diffraction (XRD) using a Bruker D2 Phaser diffractometer with Cu-Kα radiation. Samples were analyzed in the range of 6° to 50° (2θ) with a step of 0.04° at a speed of 2° / min. EXAMPLE 3. SOLID DISPERSION OF FLORETIN AND BAMBOO EXTRACT
[0158] Bamboo extract, as described in example 1, and phloretin, as described in example 2, were ground in a ball mill, in a weight ratio of 70 / 30, to obtain a phloretin-based solid dispersion, under the following process conditions:
[0159] • TMAX XQM-2 ball mill (China).
[0160] • Stainless steel spheres (9 spheres with diameter Petition 870260002279, dated 09 / 01 / 2026, page 43 / 67 36 / 49 of 1.5 cm; 22 spheres with a diameter of 1.2 cm; 60 spheres with a diameter of 1 cm and 100 spheres with a diameter of 0.8 cm)
[0161] · Rotation speed: 450 rpm
[0162] • Container volume: 500 ml
[0163] • Time: 120 minutes
[0164] • Unidirectional rotation (no change of direction during grinding)
[0165] The solid dispersion of bamboo extract and phloretin obtained by grinding in a ball mill (also referred to here as composition 303DS02) was characterized by X-ray diffraction and the reflections obtained were compared to a physical mixture of bamboo silica extract and pure crystalline phloretin material with the same phloretin content. The comparison of the reflection of both materials can be observed in Figure 5, which shows the intensity (I) of the X-ray reflections of the composition as a function of 2θ, where 2Θ is the angle between the incident ray and the reflected ray.
[0166] The characterization of the amorphous or crystalline state of the composition was performed by X-ray diffraction (XRD) using a Bruker D2 Phaser diffractometer with Cu-Kα radiation. The samples were analyzed in the range of 6° to 50° (2θ) with a step of 0.04° at a speed of 2° / min.
[0167] Comparison of X-ray reflections of solid dispersion of phloretin-bamboo extract and of the physical mixture between pure crystalline phloretin material and bamboo silica extract shows that the ball mill grinding process amorphized phloretin, since the intensities of the characteristic X-ray reflections of phloretin decrease after the ball mill grinding process. EXAMPLE 4. COMPARISON OF THE KINETICS OF FLORETIN RELEASE
[0168] The release kinetics of phloretin in solid dispersion obtained by grinding in a ball mill with bamboo silica extract as support (example 3) was compared to the release kinetics of phloretin in material Petition 870260002279, dated 09 / 01 / 2026, page 44 / 67 37 / 49 pure crystalline (example 2) under the release conditions described below:
[0169] · Apparatus: Type II dissolution apparatus (paddles) of European Pharmacopoeia - AT Xtend (Sotax)
[0170] • Dissolution medium: Ultrapure water
[0171] • Average volume: 900 ml
[0172] • Rotation speed: 75 rpm
[0173] • Agitator: paddles
[0174] • Average temperature: 37.0 °C ± 0.5 °C
[0175] • Sampling volume: 5 ml filtered through a PTFE membrane (0.45 µm) - syringe filter. Fresh culture medium (ultrapure water) is added to each vial where the sample was taken.
[0176] · Sampling frequency: 0.25 h; 0.5 h; 1 h; 2 h
[0177] · Dose of phloretin per sample: 50mg
[0178] The comparison of the phloretin release kinetics of both products is shown in Figure 6. The release test demonstrates that the amount of phloretin dissolved in the pure crystalline material reaches 40% by weight of the dissolved active ingredient after 2 hours at 37 °C in water. For the phloretin solid dispersion obtained with bamboo silica extract as support (303DS02), this amount reaches approximately 87% by weight.
[0179] The amount of phloretin released increases by a factor of 2.2 when it is in the form of a solid dispersion with the specific properties of bamboo silica extract in terms of specific surface area, pore size distribution and particle size distribution, as described in Example 2.
[0180] Next, the phloretin release kinetics of the solid dispersion with bamboo silica extract as support was compared with that of a solid dispersion with synthetic mesoporous silica as support. The synthetic silica (OSI100) showed a high specific surface area of 680 m2 / geo with the same phloretin content (30% by weight) as the solid dispersion of phloretin with Petition 870260002279, dated 09 / 01 / 2026, page 45 / 67 38 / 49 bamboo silica extract as a carrier.
[0181] A comparison of the phloretin release kinetics from both products, according to the release conditions described above, is shown in Figure 7.
[0182] The release kinetics of both phloretin-based solid dispersion materials (i.e., that obtained with synthetic amorphous mesoporous silica (OSI100) with a high specific surface area of 680 m2 / geo and that obtained with bamboo silica extract) is comparable, wherein the phloretin dispersion with bamboo extract releases more phloretin during the first hour. From 1 hour onwards, and considering the standard deviation of the assays, the phloretin release kinetics is the same for both materials and, after 2 hours, the amount of phloretin released is between 80 and 85% in both cases.
[0183] This is a surprising result, since, in general, a larger specific surface area of a mesoporous material is directly correlated with a greater release of a charged compound in the material. EXAMPLE 5. HIGH PURITY POLYGONUM CUSPIDATUM EXTRACT (>95% TRANS-REVERATROL)
[0184] Trans-resveratrol is extracted from the root of Polygonum cuspidatum (Reynoutria japonica). Trans-resveratrol powder is a crystalline material, as shown by the X-ray reflection in Figure 8.
[0185] The characterization of the amorphous or crystalline state of the trans-resveratrol raw material was performed by X-ray diffraction (XRD) using a Bruker D2 Phaser diffractometer with Cu-Kα radiation. Samples were analyzed in the range of 6° to 50° (2θ) with a step of 0.04° at a speed of 2° / min. EXAMPLE 6. SOLID DISPERSION OF TRANS-RESVERATROL AND BAMBOO SILICA EXTRACT
[0186] Bamboo silica extract, as described in Example 1, and trans-resveratrol, as described in Example 5, are ground into Petition 870260002279, dated 09 / 01 / 2026, pp. 46 / 67 39 / 49 ball mill, in a weight ratio of 70 / 30, to obtain a trans-resveratrol-based solid dispersion, according to the process conditions described in Example 3.
[0187] The trans-resveratrol-based solid dispersion with bamboo silica extract as carrier (also referred to herein as composition 303DS06) was characterized by X-ray diffraction and the reflections obtained were compared to a physical mixture of bamboo silica extract and pure crystalline trans-resveratrol material.
[0188] Comparison of X-ray reflections of 303DS06 and the physical mixture between pure crystalline trans-resveratrol material and bamboo silica extract shows that the ball milling process amorphized trans-resveratrol, since the intensities of the characteristic X-ray reflections of trans-resveratrol decrease after the ball milling process (Figure 9). EXAMPLE 7. COMPARISON OF THE RELEASE KINETICS OF TRANS-RESVERATROL
[0189] The kinetic release of trans-resveratrol from a solid dispersion of trans-resveratrol obtained by grinding in a ball mill with bamboo silica extract as support (example 6) was compared to the kinetic release of trans-resveratrol from the pure crystalline material (example 5) under the release conditions described in example 4, with a dose of 50 mg of trans-resveratrol per sample.
[0190] The comparison of the release kinetics of trans-resveratrol from both products is shown in Figure 10. The release test demonstrates that the amount of trans-resveratrol dissolved in the pure crystalline material reaches 40% by weight of the dissolved active ingredient after 2 hours at 37 °C in water. For the solid dispersion of trans-resveratrol with bamboo silica extract as a carrier (303DS06), this amount reaches approximately 80% by weight. Thus, the amount of trans-resveratrol dissolved after 2 hours in water at 37 °C increases by a factor of 2 when it is in the form of a solid dispersion with the extract of Petition 870260002279, dated 09 / 01 / 2026, page 47 / 67 40 / 49 bamboo silica as a support, compared to pure crystalline material.
[0191] Next, the release kinetics of trans-resveratrol from the solid dispersion with bamboo silica extract as carrier (303DS06) was compared with the solid dispersion of trans-resveratrol with a synthetic amorphous mesoporous silica OSI100 (also referred to herein as composition 303DS05) with a high specific surface area (680 m2 / g). The same trans-resveratrol content (30 wt%) was used and the comparison was performed under the release conditions described in Example 4.
[0192] A comparison of the release kinetics of transresveratrol from both products is shown in Figure 11.
[0193] The release kinetics of both trans-resveratrol-based solid dispersion materials, obtained with synthetic amorphous mesoporous silica (OSI100) with a high specific surface area of 680 m2 / ge with bamboo silica extract, are comparable. The kinetic curve profiles are similar, and the amount released after 2 hours is between 75 and 80% in both cases, considering the standard deviation of the tests (Figure 11).
[0194] These data confirm the surprising results of example 4. In general, a larger specific surface area of a mesoporous material is directly related to a greater release of a charged compound in the material. Therefore, composition 303DS05, comprising synthetic amorphous mesoporous silica (OSI100) with a surface area of 680 m2 / g, is expected to release a significantly greater amount of the charged compound compared to composition 303DS06, comprising bamboo mesoporous silica with a surface area around 350 to 400 m2 / g. However, the compositions including bamboo mesoporous silica released comparable amounts of the charged compound relative to the compositions containing synthetic silica, with an even greater release during the first hour, for both compounds tested. EXAMPLE 8. BAMBOO SILICA EXTRACT AS A SOURCE OF BIOAVAILABLE SILICON Petition 870260002279, dated 09 / 01 / 2026, pp. 48 / 67 41 / 49
[0195] Next, it was investigated whether bamboo silica extract could also be used as a source of bioavailable silicon. Silica is known to be not easily absorbed by the body. To make silicon more bioavailable, it needs to be broken down into smaller, more soluble forms. Calcium and magnesium are known to help break down silica into more bioavailable forms of silicon. This is because calcium and magnesium ions have a greater affinity for oxygen than silicon, and can thus help displace oxygen atoms in silica and release silicon.
[0196] Therefore, mixtures were made with Aquamin TG, a natural and highly bioactive source of minerals rich in calcium and magnesium. Aquamin TG is produced from calcareous marine algae (Lithothamnion sp.) collected from the seabed of the North Atlantic.
[0197] The composition of Aquamin TG is subject to seasonal variations. However, some typical characteristics and values are listed below. Table 2 summarizes the main physical and chemical properties of Aquamin TG algae extract. Property Value Calcium content 30% minimum Magnesium content 2.2% minimum Moisture 5% maximum Particle size 500 µm (max.) Apparent density 0.7 to 0.9 g / cm3
[0198] Several compositions were evaluated, in which unmodified corn starch was added as a granulating agent. COMPOSITION A: Ingredients Description Ratio (in % by weight) Petition 870260002279, dated 09 / 01 / 2026, page 49 / 67 42 / 49 Bamboo extract with a minimum content of 75% mesoporous silica. Mesoporous silica (>75%) Synthesis Origin: Bambusa arundinaceae; Part of the plant used: young shoots 55 Aquamin TG INGREDIENT LITHOS Aquamin TG is produced from a natural mineral source - calcareous marine algae (Lithothamnion sp.). 36 CompactCel® F300.23 FLO Release agent that loosens powder mixtures and improves flowability. 9 COMPOSITION B: Ingredients Description Ratio (in % by weight) Bamboo extract with a minimum content of 75% mesoporous silica. Mesoporous silica (>75%) Synthesis Origin: Bambusa arundinaceae; Part of the plant used: young shoots 29 Aquamin TG INGREDIENT LITHOS Aquamin TG is produced from a natural mineral source - calcareous marine algae (Lithothamnion sp.). 66 CompactCel® F300.23 FLO Release agent that loosens powder mixtures and improves flowability. 5 COMPOSITION C: Ingredients Description Ratio (in % by weight) Bamboo extract with a minimum content of 75% mesoporous silica. Mesoporous silica (>75%) Synthesis Origin: Bambusa arundinaceae; Part of the plant used: young shoots 100 COMPOSITION D: Ingredients Description Ratio (in % of Petition 870260002279, dated 09 / 01 / 2026, pp. 50 / 67 43 / 49 (weight) Bamboo extract with a minimum silica content of 75%. Silica (>75%) Synthesis Origin: Bambusa arundinacea Exudate extract Plant part used: Dried resin (= exudate clarified by boiling) 58 Aquamin TG INGREDIENT LITHOS Aquamin TG is produced from a natural mineral source - calcareous seaweed (Lithothamnion sp.). 40 CompactCel® F300.23 FLO Release agent that loosens powder mixtures and improves flowability. 2
[0199] The degradation behavior of the different compositions was characterized by ICP-OES (Agilent 5110 VDV) to evaluate the amount of silica degraded as a function of time, using the following conditions:
[0200] - Apparatus: Type II dissolution apparatus (paddles) of European Pharmacopoeia - AT Xtend (Sotax)
[0201] - Dissolution medium: FaSSIF (Intestinal Fluid in Fasting state
[0202] - Average volume: 900 ml
[0203] - Rotation speed: 75 rpm
[0204] - Agitator: paddles
[0205] - Average temperature: 37.0 °C ± 0.5 °C
[0206] - Sampling volume: 5 ml filtered through a PTFE membrane (0.45 µm) - syringe filter. Fresh culture medium (FaSSIF) is added to each vial where the sample was taken.
[0207] - Sampling frequency: 6 h h 8 h
[0208] No specific sample preparation was performed after collection during the dissolution test. Calibration curves in FaSSIF medium were prepared with Si (silicon) concentrations ranging from 1.5 to 25 ppm.
[0209] Results are expressed as a percentage of Petition 870260002279, dated 09 / 01 / 2026, pp. 51 / 67 44 / 49 amount of dissolved silicon and calculated as a function of the amount of silicon introduced into the medium.
[0210] The percentage of dissolved Si for compositions A, B, C and D was evaluated by means of dissolution tests and the results are presented in figure 12.
[0211] Bamboo silica extract derived from young shoots and composed of >70% mesoporous silica (Composition C) did not dissolve after 8 hours in aqueous medium (FaSSIF). Less than 1% silicon was released (Figure 12). However, when the bamboo silica extract was mixed with Aquamin TG as in composition A (36% Aquamin TG), the amount of dissolved silicon reached approximately 88% by weight after 8 hours in FaSSIF at 37 °C. Interestingly, composition D, comprising bamboo extract from the exudate and Aquamin TG in the same silica / Aquamin ratio as composition A, released virtually no silicon in the dissolution test (Figure 12).
[0212] The only parameter that differentiates compositions A and D is the origin of the bamboo silica extract. The silica used in composition A comes from young bamboo shoots. The silica present is mesoporous silica. The substance used in composition D comes from exudates and the silica present is not mesoporous.
[0213] The origin of the bamboo silica extract has a great influence on the dissolution of these silicas in materials in the presence of alkali or alkaline earth metals (Ca and Mg).
[0214] Furthermore, when the amount of Aquamin TG increased, as in composition B (66% by weight of Aquamin TG) compared with composition A (36% by weight of Aquamin TG), the amount of dissolved silicon decreased from 87.5% by weight to 83.5% by weight after 8 hours in FaSSIF at 37 °C.
[0215] These results indicate that the amount of dissolved silicon is related to the amount of lithothamnium introduced into the medium and that the ideal expected amount of dissolved silicon should be achieved when the Petition 870260002279, dated 09 / 01 / 2026, pp. 52 / 67 45 / 49 The amount of lithothamnium is between 15 and 55% of the mixture. For larger amounts of lithothamnium (50 to 90%), the amount of dissolved silicon decreases. EXAMPLE 9. GRINDING BAMBOO EXTRACT FURTHER INCREASES THE BIOAVAILABILITY OF SILICON.
[0216] To obtain a completely natural product where the silica content is completely soluble, the silica extract from young bamboo shoots was processed by grinding in a ball mill to reduce the particle size. By reducing the particle size, the contact surface area increases and the dissolution kinetics of silicon should be accelerated.
[0217] Extracted bamboo silica, obtained after the grinding process in a ball mill under the conditions described previously in Example 3, was used in combination with Aquamin TG, describing composition E. COMPOSITION AND: Ingredients Description Ratio (in % by weight) Ground bamboo extract with a minimum silica content of 75%. Mesoporous silica (>75%) Synthesis Origin: Bambusa arundinaceae; Part of the plant used: young shoots 55 Aquamin TG INGREDIENT LITHOS Aquamin TG is produced from a natural mineral source - calcareous marine algae (Lithothamnion sp.). 36 CompactCel® F300.23 FLO Release agent that loosens powder mixtures and improves flowability. 9
[0218] The particle size distribution of bamboo silica extract obtained from young shoots after grinding in a ball mill was determined by a particle size analyzer using the Beckman Coulter method in water at room temperature. The particle size distribution in the volume of the material is centered at 14.50 µm. More specifically, the following parameters of the particle size distribution were obtained. Petition 870260002279, dated 09 / 01 / 2026, pp. 53 / 67 46 / 49 of this material: TABLE 3. MAIN DISTRIBUTION PARAMETERS PARTICLE SIZE BY VOLUME OF BAMBOO SILICA EXTRACT OBTAINED FROM YOUNG SHOOTS AFTER GRINDING IN A BALL MILL. d10 (pm) d25 (pm) d50 (pm) d75 (pm) d90 (pm) 3.34 6.67 14.49 31.39 79.44
[0219] After grinding in a ball mill, the average particle size of the bamboo silica extract decreases by a factor of 7.4 when comparing the d50 before (107 pm) and after grinding in a ball mill (14.49 pm). Subsequently, the percentage of dissolved Si in composition E was evaluated by the dissolution test.
[0220] As shown in Figure 12, reducing the particle size of the bamboo silica extract by grinding in a ball mill further increased the percentage of dissolved silicon, more specifically by approximately 13% by weight after 8 hours in FaSSIF compared to composition A. Interestingly, under the conditions of composition E, the silicon content dissolves completely after 8 hours in FaSSIF at 37 °C. EXAMPLE 10. DISSOLUTION OF SILICON FROM A BAMBOO SILICA EXTRACT AT DIFFERENT TEMPERATURES AND IN THE PRESENCE OF A CALCIUM SALT.
[0221] Finally, the dissolution kinetics of the silica extract from young bamboo shoots at different temperatures was studied. For this purpose, a composition F was created, the specifics of which are detailed below.
[0222] 945 mg of composition F were introduced into 500 ml of ultrapure water at the following temperatures: 23 °C; 41 °C; 50 °C and 60 °C.
[0223] After 0.5 h; 1 h; 2 h and 3 h, a 5 ml sample was taken and the product was filtered through a polytetrafluoroethylene (PTFE) filter (0.45 µm). Petition 870260002279, dated 09 / 01 / 2026, pp. 54 / 67 47 / 49 COMPOSITION F: Ingredients Description Ratio (in % by weight) Bamboo extract with a minimum silica content of 75%. Mesoporous silica (>75%) Synthesis Origin: Bambusa arundinaceae; Part of the plant used: young shoots 38 Calcium acetate CAS: 62-54-4 E263 C4H6CaO4 62
[0224] The amount of dissolved silicon in the samples was evaluated by ICP-OES with a calibration curve where the silicon concentration ranged from 0 to 50 ppm Si. The samples were diluted 10 times in ultrapure water before analysis. The dissolution kinetic curves for each temperature studied are shown in Figure 13.
[0225] The evolution of Si content in ultrapure water of composition F is highlighted in figure 14 and follows an exponential trend as a function of temperature. EXAMPLE 11 - INFLUENCE OF GRINDING CONDITIONS ON SOLUBILITY AND RESULTING COMPOSITION
[0226] A commercially available silica extract, derived from bamboo, was analyzed and subsequently ground in a ball mill under different conditions. The silica extract contained 68% silica (SO2).
[0227] 100 mg of bamboo extract were ground in a ball mill with a BPR ratio of 7.6 at a fixed RPM of 450 for 4 hours. The initial and resulting compositions were analyzed and placed in FaSSIF at 37 °C for 4, 6, and 8 hours. The amount of dissolved silicon was measured by ICP-OES. The dissolved amount of silicon is elemental silicon (Si), not silica (SiO2).
[0228] The silica extract before grinding had a specific surface area of 288 m2 / g. After 2 hours of grinding in a ball mill, the specific surface area was reduced to 172 m2 / g, indicating the effect Petition 870260002279, dated 09 / 01 / 2026, pp. 55 / 67 48 / 49 destructive grinding in a ball mill on highly porous structures. All calculations were made according to BET theory.
[0229] Figure 15 shows the amount of silicon (mg) dissolved in FaSSIF at 37 °C after 4, 6, and 8 hours, before and after the extracts were milled in a ball mill for 8 hours (7.6 BPR, 450 RPM, milling time of 8 hours). It is evident that milling in a ball mill significantly increased the amount of silicon dissolved in FaSSIF at each of these periods.
[0230] The experiment was repeated with a fixed grinding time of 4 hours, varying the BPR ratio and keeping the rotation fixed at 450 RPM. The resulting composition was analyzed and placed in FaSSIF at 37 °C for 8 hours. The amount of dissolved silicon was investigated.
[0231] Figure 16 shows the amount of silicon (mg) dissolved in FaSSIF at 37 °C after 8 hours, as a function of the BPR ratio under the previously mentioned milling conditions (450 RPM, 4 hours milling time). Figure 17 shows the average particle size as a function of the BPR ratio under the same milling conditions. The optimum value is obtained with a BPR ratio of 5.5. At this point, further increases in the dissolution rate and / or particle size are limited, especially given the rapidly increasing energy requirements at such high BPR ratios.
[0232] The experiment was repeated with a BPR ratio of 0.8 and a fixed rotation of 450 RPM. The milling time was varied. Figure 18 shows the amount of silicon (mg) dissolved in FaSSiF at 37 °C after 8 hours, as a function of milling time (h). For this BPR and RPM ratio, it is evident that an optimal milling time is obtained around 4 hours. Further increases in milling time do not result in benefits for the silicon dissolution rate. EXAMPLE 12 - ADDITION OF CALCIUM SALTS
[0233] The influence of calcium salts on a variety of mesoporous silicas with different specific surface areas was investigated. When the specific surface area of the silica was greater than 650 m2 / g, it was observed Petition 870260002279, dated 09 / 01 / 2026, pp. 56 / 67 49 / 49 a very significant increase. In fact, very high silicon dissolution rates can be obtained. However, when the specific surface area of silica was less than 550 m² / g, the increase after the addition of calcium was limited. For silica with a surface area less than 350 m² / g, practically no benefit was observed with the addition of calcium. Without adhering to theory, it is believed that dissolved Ca²⁺ ions affect the dissolution and gelation kinetics at the water-silica interface and, particularly, destabilize structures with high specific surface area. Petition 870260002279, dated 09 / 01 / 2026, pp. 57 / 67
Claims
1 / 3 CLAIMS 1. Composition comprising a silica extract derived from bamboo, wherein said composition is characterized in that it exhibits a silicon (Si) dissolution of at least 3% by weight relative to the silicon in the composition, in FaSSIF after 8 hours at 37 °C, as measured by ICP-OES.
2. Composition according to claim 1, wherein said composition is characterized in that it exhibits a silicon (Si) dissolution of at least 5% by weight relative to the silicon in the composition, in FaSSIF after 8 hours at 37 °C, as measured by ICP-OES.
3. Composition, according to any one of claims 1 to 2, wherein said composition is characterized by a silicon (Si) dissolution of at least 7% by weight relative to the silicon in the composition, in FaSSIF after 8 hours at 37 °C, as measured by ICP-OES.
4. Composition, according to any one of claims 1 to 3, characterized in that said composition comprises silica SiO2 in an amount of at least 50% by weight.
5. Composition, according to any one of claims 1 to 4, characterized in that said composition has an average particle size d50 between 0.05 and 1.00 pm, as determined by the Beckman Coulter method in water at room temperature.
6. Composition, according to any one of claims 1 to 5, characterized in that said composition has an average particle size d50 between 0.1 and 0.5 pm, as determined by the Beckman Coulter method in water at room temperature.
7. Composition, according to any one of claims 1 to 6, characterized in that said composition has a specific surface area calculated from nitrogen sorption isotherms at the temperature of liquid nitrogen (77 K) by the Brunauer, Emmett and Teller (BET) theory, of at most 600 m2 / g, more preferably between 100 m2 / g and 300 m2 / g.
8. Method for producing a soluble silica composition, Petition 870250103097, dated 11 / 11 / 2025, pp. 122 / 128 2 / 3 the method is characterized in that it comprises the steps of: - providing a grinding composition, said composition comprising a silica extract derived from bamboo in an amount of at least 30% by weight relative to the composition; and - grinding spheres of said grinding composition, thereby obtaining a soluble silica composition.
9. Method according to claim 8, characterized in that the grinding of spheres is carried out at a sphere-to-powder ratio (SPR) by weight between 3.0 and 8.0, preferably between 3.5 and 7.
0.
10. Method according to claim 8 or 9, characterized in that the grinding time is between 3.0 and 8.0 hours, preferably between 3.5 and 5.0 hours.
11. Method, according to any one of claims 8 to 10, characterized in that the average particle size d50 of the soluble silica composition is between 0.1 and 0.5 pm, as determined by the Beckman Coulter method in water at room temperature.
12. Method, according to any one of claims 8 to 11, characterized in that the average particle size d50 of the grinding composition is greater than 2.5 pm, as determined by the Beckman Coulter method in water at room temperature.
13. A method, according to any one of claims 8 to 12, characterized in that the soluble silica composition has a specific surface area calculated from nitrogen sorption isotherms at the temperature of liquid nitrogen (77 K) by the Brunauer, Emmett and Teller (BET) theory between 100 m2 / g and 300 m2 / g.
14. Method, according to any one of claims 8 to 13, characterized in that the grinding composition has a specific surface area calculated from nitrogen sorption isotherms at the temperature of liquid nitrogen (77 K) by the Brunauer, Emmett and Teller (BET) theory above 250 m² / g. Petition 870250103097, dated 11 / 11 / 2025, pp. 123 / 128 3 / 3 15.A method for producing a soluble silica composition, the method is characterized by the fact that it comprises the steps of: - providing an insoluble composition, said composition comprising a silica extract derived from bamboo in an amount of at least 30% by weight relative to the composition; and - measuring the specific surface area calculated from nitrogen sorption isotherms at liquid nitrogen temperature (77 K) by the Brunauer, Emmett and Teller (BET) theory of said insoluble composition; - when the specific surface area of the insoluble composition is greater than 650 m2 / g, a calcium salt is added to the insoluble composition in an amount of at least 10% by weight relative to the weight of the silica extract; thus obtaining the soluble silica composition; and - when the specific surface area of the insoluble composition is less than 650 m2 / g, said insoluble composition is ground in a ball mill, thus obtaining the soluble silica composition.Petition 870250103097, dated 11 / 11 / 2025, pp. 124 / 128.
